Analysis of carnitine biosynthesis metabolites in urine by HPLC-electrospray tandem mass spectrometry

Frédéric M. Vaz, Bela Melegh, Judit Bene, Dean Cuebas, Douglas A. Gage, Albert Bootsma, Peter Vreken, Albert H. Van Gennip, Loran L. Bieber, Ronald J.A. Wanders

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background: We developed a method to determine the urinary concentrations of metabolites in the synthetic pathway for carnitine from N6-trimethyllysine and applied this method to determine their excretion in control individuals. In addition, we investigated whether newborns are capable of carnitine synthesis from deuterium-labeled N6-trimethyllysine. Methods: Urine samples were first derivatized with methyl chloroformate. Subsequently, the analytes were separated by ion-pair, reversed-phase HPLC and detected online by electrospray tandem mass spectrometry. Stable-isotope-labeled reference compounds were used as internal standards. Results: The method quantified all carnitine biosynthesis metabolites except 4-N-trimethylaminobutyraldehyde. Detection limits were 0.05-0.1 μmol/L. The interassay imprecision (CV) for urine samples with added compounds was 6-12%. The intraassay imprecision (CV) was 1-5% (3-10 μmol/L). Recoveries were 94-106% at 10-20 μmol/L and 98-103% at 100-200 μmol/L. The mean (SD) excretions of N6-trimethyllysine and 3-hydroxy-N6-trimethyllysine were 2.8 (0.8) and 0.45 (0.15) mmol/mol creatinine, respectively. γ-Butyrobetaine and carnitine excretions were more variable with values of 0.27 (0.21) and 15 (12) mmol/mol creatinine, respectively. After oral administration of deuterium-labeled N6-trimethyllysine, all urines of newborns contained deuterium-labeled N6-trimethyllysine, 3-hydroxy-N6-trimethyllysine, γ-butyrobetaine, and carnitine. Conclusions: HPLC in combination with electrospray ionization tandem mass spectrometry allows rapid determination of urinary carnitine biosynthesis metabolites. Newborns can synthesize carnitine from exogenous N6-trimethyllysine, albeit at a low rate.

Original languageEnglish
Pages (from-to)826-834
Number of pages9
JournalClinical chemistry
Volume48
Issue number6
DOIs
Publication statusPublished - Jan 1 2002

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Analysis of carnitine biosynthesis metabolites in urine by HPLC-electrospray tandem mass spectrometry'. Together they form a unique fingerprint.

  • Cite this

    Vaz, F. M., Melegh, B., Bene, J., Cuebas, D., Gage, D. A., Bootsma, A., Vreken, P., Van Gennip, A. H., Bieber, L. L., & Wanders, R. J. A. (2002). Analysis of carnitine biosynthesis metabolites in urine by HPLC-electrospray tandem mass spectrometry. Clinical chemistry, 48(6), 826-834. https://doi.org/10.1093/clinchem/48.6.826